Hemicrania Continua is a rare primary headache disorder characterized by continuous, unilateral pain that varies in intensity. It is often accompanied by autonomic symptoms such as nasal congestion, tearing, and redness of the eye on the affected side. The condition is typically responsive to treatment with indomethacin, a nonsteroidal anti-inflammatory drug (NSAID). However, some patients may not respond to or tolerate indomethacin, requiring alternative treatment options.
Indomethacin is the first-line treatment for hemicrania continua. It is a potent NSAID that effectively relieves pain and associated symptoms in most patients. The recommended starting dose is 25 mg three times a day, which can be increased up to 200 mg per day if necessary. Regular monitoring of blood pressure, kidney function, and gastrointestinal side effects is essential during indomethacin treatment.
If a patient does not respond to or cannot tolerate indomethacin, other NSAIDs such as naproxen, diclofenac, or celecoxib may be considered. These medications can provide relief for some individuals, although they are generally less effective than indomethacin.
Topiramate, an antiepileptic drug, has shown promise in the treatment of hemicrania continua. It can be used as an alternative or adjunct to indomethacin. The starting dose is usually 25 mg per day, which can be gradually increased to a maximum of 200 mg per day. Topiramate may be particularly beneficial for patients who experience side effects from indomethacin or have contraindications to NSAIDs.
Occipital nerve block involves injecting a local anesthetic and corticosteroid around the occipital nerves at the back of the head. This procedure can provide temporary relief from hemicrania continua symptoms. It is typically performed by a headache specialist and may need to be repeated periodically.
In cases where indomethacin, other NSAIDs, or topiramate are ineffective or not tolerated, additional medications may be considered. These include melatonin, gabapentin, verapamil, and botulinum toxin injections. However, the evidence for their effectiveness in hemicrania continua is limited, and their use should be guided by a healthcare professional.
While not a direct treatment for hemicrania continua, certain lifestyle modifications can help manage the condition and reduce the frequency and severity of headaches. These include maintaining a regular sleep schedule, managing stress levels, avoiding triggers such as certain foods or environmental factors, and engaging in regular exercise.
It is important for individuals with hemicrania continua to consult with a healthcare professional, preferably a headache specialist, to determine the most appropriate treatment plan. Each patient's response to treatment may vary, and a personalized approach is necessary to achieve optimal outcomes.